CETN1
gene geneOn this page
Also known as CEN1
Summary
CETN1 (centrin 1, HGNC:1866) is a protein-coding gene on chromosome 18p11.32, encoding Centrin-1 (Q12798). Plays a fundamental role in microtubule-organizing center structure and function.
The protein encoded by this gene plays important roles in the determination of centrosome position and segregation, and in the process of microtubule severing. This protein is localized to the centrosome of interphase cells, and redistributes to the region of the spindle poles during mitosis, reflecting the dynamic behavior of the centrosome during the cell cycle.
Source: NCBI Gene 1068 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 33 total — 1 pathogenic
- MANE Select transcript:
NM_004066
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1866 |
| Approved symbol | CETN1 |
| Name | centrin 1 |
| Location | 18p11.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CEN1 |
| Ensembl gene | ENSG00000177143 |
| Ensembl biotype | protein_coding |
| OMIM | 603187 |
| Entrez | 1068 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000327228
RefSeq mRNA: 1 — MANE Select: NM_004066
NM_004066
CCDS: CCDS11820
Canonical transcript exons
ENST00000327228 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001231082 | 580380 | 582114 |
Expression profiles
Bgee: expression breadth broad, 32 present calls, max score 97.30.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2966 / max 316.6617, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 169052 | 0.2511 | 4 |
| 169051 | 0.0455 | 3 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.30 | gold quality |
| right testis | UBERON:0004534 | 97.14 | gold quality |
| testis | UBERON:0000473 | 93.72 | gold quality |
| sperm | CL:0000019 | 92.23 | gold quality |
| male germ cell | CL:0000015 | 91.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.90 | gold quality |
| adult organism | UBERON:0007023 | 81.70 | gold quality |
| olfactory bulb | UBERON:0002264 | 78.54 | gold quality |
| type B pancreatic cell | CL:0000169 | 78.46 | gold quality |
| diaphragm | UBERON:0001103 | 75.04 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 72.60 | gold quality |
| hair follicle | UBERON:0002073 | 72.34 | gold quality |
| oocyte | CL:0000023 | 69.52 | gold quality |
| pancreatic ductal cell | CL:0002079 | 68.56 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 67.60 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 65.20 | gold quality |
| upper arm skin | UBERON:0004263 | 64.78 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 64.36 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 63.85 | gold quality |
| gingival epithelium | UBERON:0001949 | 63.84 | gold quality |
| mammary duct | UBERON:0001765 | 63.49 | gold quality |
| cervix epithelium | UBERON:0004801 | 63.38 | gold quality |
| secondary oocyte | CL:0000655 | 63.23 | gold quality |
| ileal mucosa | UBERON:0000331 | 63.18 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 63.02 | gold quality |
| thymus | UBERON:0002370 | 62.18 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 61.70 | gold quality |
| gingiva | UBERON:0001828 | 61.37 | gold quality |
| cardia of stomach | UBERON:0001162 | 60.98 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 60.97 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 29.55 |
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
47 targeting CETN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-4690-5P | 99.65 | 66.24 | 813 |
| HSA-MIR-26A-1-3P | 99.64 | 66.81 | 788 |
| HSA-MIR-26A-2-3P | 99.64 | 66.82 | 786 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-4643 | 99.49 | 67.63 | 1791 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-21-5P | 99.46 | 70.54 | 1035 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-590-5P | 99.25 | 70.76 | 930 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
| HSA-MIR-548AS-3P | 99.12 | 69.12 | 2294 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-3184-5P | 98.56 | 67.13 | 1491 |
Literature-anchored findings (GeneRIF, showing 7)
- These data demonstrate a functional role for CaM binding to CP110 and suggest that CP110 cooperates with CaM and centrin to regulate progression through cytokinesis. (PMID:16760425)
- CETN1 is overexpressed in breast cancer tissue and promotes cells’proliferation, tumor growth and metastasis. (PMID:25261648)
- A chirality change in XPC- and Sfi1-derived peptides affects their affinity for centrin. (PMID:26923803)
- important spectral and hydrodynamic characteristics of human Centrin-1, accounting that HsCentrin-1 has moderate affinity for Ca(2+). Centrin-1 does not gain structure as seen by far- and near-UV circular dichroism, rather there is a loss of ellipticity, though inconsiderable upon binding Ca(2+). (PMID:27235176)
- Conformational scanning of individual EF-hand motifs of calcium sensor protein centrin-1. (PMID:34273620)
- Exome sequencing and functional analyses revealed CETN1 variants leads to impaired cell division and male fertility. (PMID:36048845)
- Human SFI1 and Centrin form a complex critical for centriole architecture and ciliogenesis. (PMID:36125182)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cetn2 | ENSDARG00000101510 |
| mus_musculus | Cetn1 | ENSMUSG00000050996 |
| rattus_norvegicus | Cetn1 | ENSRNOG00000084288 |
| drosophila_melanogaster | CG17493 | FBGN0040010 |
| drosophila_melanogaster | CG31802 | FBGN0051802 |
| caenorhabditis_elegans | WBGENE00000285 | |
| caenorhabditis_elegans | WBGENE00000287 | |
| caenorhabditis_elegans | pat-10 | WBGENE00003934 |
| caenorhabditis_elegans | WBGENE00008453 | |
| caenorhabditis_elegans | F35C12.3 | WBGENE00009408 |
| caenorhabditis_elegans | WBGENE00015264 |
Paralogs (20): CABP7 (ENSG00000100314), CABP5 (ENSG00000105507), CALML4 (ENSG00000129007), CALM2 (ENSG00000143933), CETN2 (ENSG00000147400), CETN3 (ENSG00000153140), CABP1 (ENSG00000157782), CALM3 (ENSG00000160014), CABP2 (ENSG00000167791), CALML6 (ENSG00000169885), EFCAB3 (ENSG00000172421), EFCAB12 (ENSG00000172771), CABP4 (ENSG00000175544), CALML3 (ENSG00000178363), CALML5 (ENSG00000178372), CALN1 (ENSG00000183166), CALM1 (ENSG00000198668), EFCAB2 (ENSG00000203666), EFCAB7 (ENSG00000203965), EFCAB9 (ENSG00000214360)
Protein
Protein identifiers
Centrin-1 — Q12798 (reviewed: Q12798)
Alternative names: Caltractin isoform 2
All UniProt accessions (2): Q12798, A0A140VJG3
UniProt curated annotations — full annotation on UniProt →
Function. Plays a fundamental role in microtubule-organizing center structure and function. Plays a role in sperm cilia formation.
Subunit / interactions. Monomer. Interacts with CIMAP3. Interacts with USP49.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Cell projection. Cilium.
Miscellaneous. Binds two moles of calcium per mole of protein.
Similarity. Belongs to the centrin family.
RefSeq proteins (1): NP_004057* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000629 | RNA-helicase_DEAD-box_CS | Conserved_site |
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR050145 | Centrin_CML-like | Family |
Pfam: PF13499
UniProt features (16 total): binding site 10, domain 4, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q12798-F1 | 86.62 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (10): 52; 150; 152; 154; 156; 161; 41; 43; 45; 47
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-9613829 | Chaperone Mediated Autophagy |
| R-HSA-9615710 | Late endosomal microautophagy |
| R-HSA-9646399 | Aggrephagy |
MSigDB gene sets: 101 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CENTRIOLE_ASSEMBLY, OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN, WTGAAAT_UNKNOWN, GOCC_CENTROSOME, OCT1_06, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_RESPONSE_TO_HEAT, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOCC_NEURON_PROJECTION, GOBP_CENTROSOME_DUPLICATION, GOCC_SPINDLE, GOCC_CENTRIOLE, GOCC_MOTILE_CILIUM
GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), centriole replication (GO:0007099), cellular response to heat (GO:0034605), cell division (GO:0051301)
GO Molecular Function (6): calcium ion binding (GO:0005509), microtubule binding (GO:0008017), G-protein beta/gamma-subunit complex binding (GO:0031683), heterotrimeric G-protein binding (GO:0032795), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (11): spindle pole (GO:0000922), nucleus (GO:0005634), centrosome (GO:0005813), centriole (GO:0005814), cytosol (GO:0005829), photoreceptor connecting cilium (GO:0032391), cytoplasm (GO:0005737), microtubule organizing center (GO:0005815), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Autophagy | 2 |
| Selective autophagy | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| protein-containing complex binding | 2 |
| microtubule organizing center | 2 |
| intracellular membraneless organelle | 2 |
| cytoskeleton organization | 1 |
| microtubule-based process | 1 |
| cell cycle process | 1 |
| centrosome duplication | 1 |
| centriole assembly | 1 |
| response to heat | 1 |
| cellular response to stress | 1 |
| cellular process | 1 |
| metal ion binding | 1 |
| tubulin binding | 1 |
| binding | 1 |
| cation binding | 1 |
| spindle | 1 |
| intracellular membrane-bounded organelle | 1 |
| centriole | 1 |
| cytoplasm | 1 |
| ciliary transition zone | 1 |
| photoreceptor cell cilium | 1 |
| intracellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
2496 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CETN1 | PCNT | O95613 | 870 |
| CETN1 | NIN | Q8N4C6 | 844 |
| CETN1 | PCM1 | Q15154 | 740 |
| CETN1 | NUP85 | Q9BW27 | 714 |
| CETN1 | POC5 | Q8NA72 | 709 |
| CETN1 | SFI1 | A8K8P3 | 693 |
| CETN1 | MORN1 | Q5T089 | 677 |
| CETN1 | CEP290 | O15078 | 667 |
| CETN1 | DCTN2 | Q13561 | 646 |
| CETN1 | CEP135 | Q66GS9 | 644 |
| CETN1 | CENPA | P49450 | 643 |
| CETN1 | DCTN1 | Q14203 | 635 |
| CETN1 | CEP164 | Q9UPV0 | 631 |
| CETN1 | PLK4 | O00444 | 620 |
| CETN1 | SASS6 | Q6UVJ0 | 618 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CETN1 | POC5 | psi-mi:“MI:0915”(physical association) | 0.850 |
| POC5 | CETN1 | psi-mi:“MI:0915”(physical association) | 0.850 |
| CETN1 | SGSM1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SGSM1 | CETN1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| XPC | CETN3 | psi-mi:“MI:0914”(association) | 0.730 |
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| CETN1 | POC5 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SGSM1 | CETN1 | psi-mi:“MI:0915”(physical association) | 0.660 |
| CETN1 | SFI1 | psi-mi:“MI:0914”(association) | 0.640 |
| SNX9 | WASL | psi-mi:“MI:0914”(association) | 0.640 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| ZFAND5 | CETN1 | psi-mi:“MI:0915”(physical association) | 0.590 |
| SGSM1 | CETN2 | psi-mi:“MI:0914”(association) | 0.530 |
| PNMA2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| CETN1 | CCP110 | psi-mi:“MI:0914”(association) | 0.350 |
| USP49 | ANKRD28 | psi-mi:“MI:0914”(association) | 0.350 |
| CALN1 | CETN1 | psi-mi:“MI:0914”(association) | 0.350 |
| CNN3 | ATE1 | psi-mi:“MI:0914”(association) | 0.350 |
| LGALS3BP | ACACB | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (106): SGSM1 (Two-hybrid), POC5 (Two-hybrid), XPC (Affinity Capture-MS), POC5 (Affinity Capture-MS), SGSM1 (Affinity Capture-MS), KIAA1407 (Affinity Capture-MS), SFI1 (Affinity Capture-MS), SGSM2 (Affinity Capture-MS), EFCAB11 (Affinity Capture-MS), KIF1A (Affinity Capture-MS), TDP1 (Affinity Capture-MS), FBXO16 (Affinity Capture-MS), KIF1B (Affinity Capture-MS), CETN2 (Affinity Capture-MS), TWIST1 (Affinity Capture-MS)
ESM2 similar proteins: A0A125YHX7, A0A125YZN2, J9W034, O15182, O23184, O35648, O74435, O82659, P02597, P02599, P04352, P05434, P05933, P06704, P27163, P27164, P27482, P41041, P41208, P41209, P41210, P43645, P43646, P49258, P53440, P53441, P54213, P60204, P60205, P60206, P61859, P61860, P61861, Q06827, Q12798, Q24956, Q27177, Q27178, Q27179, Q2TBN3
Diamond homologs: A0A125YHX7, A0A125YZN2, A2WN93, A2WNH1, A2Y609, A3E3H0, A3E4D8, A3E4F9, A4UHC0, A8CEP3, A8I1Q0, J9W034, O15182, O23184, O35648, O60041, O74435, O82018, O82659, O94739, O96102, P02597, P02598, P04352, P04353, P04464, P05419, P05434, P06704, P06787, P07463, P0DH95, P0DH96, P0DH97, P0DH98, P11120, P11121, P13868, P15094, P17928
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CCP110 | “up-regulates activity” | CETN1 | binding |
| PCM1 | up-regulates | CETN1 | relocalization |
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 253646 | GRCh37/hg19 18p11.32-11.22(chr18:14316-10784606)x1 | Pathogenic |
SpliceAI
71 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:580607:G:GT | donor_gain | 0.6900 |
| 18:580643:G:T | donor_gain | 0.6900 |
| 18:580603:G:GT | donor_gain | 0.6400 |
| 18:580539:G:GT | donor_gain | 0.5800 |
| 18:580643:G:GT | donor_gain | 0.5800 |
| 18:580765:G:T | donor_gain | 0.5700 |
| 18:580573:G:GA | donor_gain | 0.5500 |
| 18:580636:G:GA | donor_gain | 0.5500 |
| 18:580765:G:GT | donor_gain | 0.5400 |
| 18:580572:T:TA | donor_gain | 0.5300 |
| 18:580511:G:GT | donor_gain | 0.5100 |
| 18:580604:A:T | donor_gain | 0.5100 |
| 18:580635:T:TA | donor_gain | 0.5000 |
| 18:580926:G:GT | donor_gain | 0.5000 |
| 18:580511:G:T | donor_gain | 0.4900 |
| 18:580942:C:G | donor_gain | 0.4900 |
| 18:580464:T:TA | donor_gain | 0.4700 |
| 18:580465:G:GA | donor_gain | 0.4700 |
| 18:580654:G:T | donor_gain | 0.4500 |
| 18:580733:GCCT:G | donor_gain | 0.4400 |
| 18:580644:A:T | donor_gain | 0.4100 |
| 18:581119:A:G | acceptor_gain | 0.4100 |
| 18:580539:G:T | donor_gain | 0.4000 |
| 18:580575:C:G | donor_gain | 0.4000 |
| 18:580615:G:GT | donor_gain | 0.3900 |
| 18:580755:A:G | donor_gain | 0.3900 |
| 18:580934:TTCAG:T | donor_gain | 0.3900 |
| 18:581118:A:AG | acceptor_gain | 0.3900 |
| 18:580648:C:T | donor_gain | 0.3800 |
| 18:580718:G:GT | donor_gain | 0.3800 |
AlphaMissense
1165 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:580517:T:C | F37L | 0.999 |
| 18:580519:T:A | F37L | 0.999 |
| 18:580519:T:G | F37L | 0.999 |
| 18:580785:T:C | L126P | 0.999 |
| 18:580796:G:C | A130P | 0.999 |
| 18:580736:T:C | F110L | 0.998 |
| 18:580738:C:A | F110L | 0.998 |
| 18:580738:C:G | F110L | 0.998 |
| 18:580745:T:C | F113L | 0.998 |
| 18:580747:T:A | F113L | 0.998 |
| 18:580747:T:G | F113L | 0.998 |
| 18:580833:T:C | L142P | 0.998 |
| 18:580853:G:C | A149P | 0.998 |
| 18:580892:T:C | F162L | 0.998 |
| 18:580894:C:A | F162L | 0.998 |
| 18:580894:C:G | F162L | 0.998 |
| 18:580524:T:C | L39P | 0.997 |
| 18:580575:C:A | A56D | 0.997 |
| 18:580589:G:C | G61R | 0.997 |
| 18:580673:T:C | F89L | 0.997 |
| 18:580675:C:A | F89L | 0.997 |
| 18:580675:C:G | F89L | 0.997 |
| 18:580743:T:C | L112P | 0.997 |
| 18:580770:T:C | I121T | 0.997 |
| 18:580770:T:G | I121S | 0.997 |
| 18:580842:T:C | M145T | 0.997 |
| 18:580842:T:G | M145R | 0.997 |
| 18:580893:T:C | F162S | 0.997 |
| 18:580514:G:C | A36P | 0.996 |
| 18:580566:T:C | L53P | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1001462669 (18:578841 G>A), RS1001827434 (18:579955 G>A), RS1002206172 (18:579635 A>G), RS1002847989 (18:582340 A>C), RS1004119797 (18:579885 T>A,G), RS1005390171 (18:582199 C>T), RS1005462096 (18:581810 CT>C), RS1005926859 (18:581310 T>G), RS1006207018 (18:580997 G>A,C), RS1007931052 (18:578791 G>T), RS1008740468 (18:579645 A>G), RS1009896178 (18:579888 T>A), RS1009976542 (18:580663 C>T), RS1011811204 (18:578598 GT>G,GTT), RS1011968640 (18:581661 G>A)
Disease associations
OMIM: gene MIM:603187 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| butyraldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.